-
Je něco špatně v tomto záznamu ?
Masked Hypertension in Healthy Children and Adolescents: Who Should Be Screened
T. Seeman, T. Šuláková, S. Stabouli
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, přehledy, práce podpořená grantem
NLK
ProQuest Central
od 2009-01-01 do Před 1 rokem
Medline Complete (EBSCOhost)
od 1999-01-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 2009-01-01 do Před 1 rokem
- MeSH
- chronická renální insuficience * MeSH
- dítě MeSH
- hypertenze * diagnóza epidemiologie MeSH
- lidé MeSH
- maskovaná hypertenze * diagnóza epidemiologie MeSH
- mladiství MeSH
- obezita MeSH
- rizikové faktory MeSH
- Check Tag
- dítě MeSH
- lidé MeSH
- mladiství MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
PURPOSE OF REVIEW: The goal is to review masked hypertension (MH) as a relatively new phenomenon when patients have normal office BP but elevated out-of-office BP. Firstly, it was described in children in 2004. It has received increased attention in the past decade. RECENT FINDINGS: The prevalence of MH in different pediatric populations differs widely between 0 and 60% based on the population studied, definition of MH, or method of out-of-office BP measurement. The highest prevalence of MH has been demonstrated in children with chronic kidney disease (CKD), obesity, diabetes, and after heart transplantation. In healthy children but with risk factors for hypertension such as prematurity, overweight/obesity, diabetes, chronic kidney disease, or positive family history of hypertension, the prevalence of MH is 9%. In healthy children without risk factors for hypertension, the prevalence of MH is very low ranging 0-3%. In healthy children, only patients with the following clinical conditions should be screened for MH: high-normal/elevated office BP, positive family history of hypertension, and those referred for suspected hypertension who have normal office BP in the secondary/tertiary center.
Department of Pediatrics Medical Faculty University of Ostrava Ostrava Czech Republic
Department of Pediatrics University Hospital Ostrava Ostrava Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23016308
- 003
- CZ-PrNML
- 005
- 20231026110036.0
- 007
- ta
- 008
- 231013s2023 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s11906-023-01260-6 $2 doi
- 035 __
- $a (PubMed)37639176
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Seeman, Tomáš $u Department of Pediatrics, Charles University Prague, 2nd Medical Faculty, V Úvalu 84, 15006, Prague, Czech Republic. tomas.seeman@lfmotol.cuni.cz $u Department of Pediatrics, University Hospital Ostrava, Ostrava, Czech Republic. tomas.seeman@lfmotol.cuni.cz $1 https://orcid.org/0000000313713096
- 245 10
- $a Masked Hypertension in Healthy Children and Adolescents: Who Should Be Screened / $c T. Seeman, T. Šuláková, S. Stabouli
- 520 9_
- $a PURPOSE OF REVIEW: The goal is to review masked hypertension (MH) as a relatively new phenomenon when patients have normal office BP but elevated out-of-office BP. Firstly, it was described in children in 2004. It has received increased attention in the past decade. RECENT FINDINGS: The prevalence of MH in different pediatric populations differs widely between 0 and 60% based on the population studied, definition of MH, or method of out-of-office BP measurement. The highest prevalence of MH has been demonstrated in children with chronic kidney disease (CKD), obesity, diabetes, and after heart transplantation. In healthy children but with risk factors for hypertension such as prematurity, overweight/obesity, diabetes, chronic kidney disease, or positive family history of hypertension, the prevalence of MH is 9%. In healthy children without risk factors for hypertension, the prevalence of MH is very low ranging 0-3%. In healthy children, only patients with the following clinical conditions should be screened for MH: high-normal/elevated office BP, positive family history of hypertension, and those referred for suspected hypertension who have normal office BP in the secondary/tertiary center.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a dítě $7 D002648
- 650 12
- $a maskovaná hypertenze $x diagnóza $x epidemiologie $7 D059468
- 650 12
- $a hypertenze $x diagnóza $x epidemiologie $7 D006973
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a obezita $7 D009765
- 650 12
- $a chronická renální insuficience $7 D051436
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Šuláková, Terezie $u Department of Pediatrics, University Hospital Ostrava, Ostrava, Czech Republic $u Department of Pediatrics, Medical Faculty, University of Ostrava, Ostrava, Czech Republic
- 700 1_
- $a Stabouli, Stella $u 1st Department of Pediatrics, School of Medicine, Faculty of Health Sciences, Aristotle University Thessaloniki, Hippokratio Hospital, Thessaloniki, Greece
- 773 0_
- $w MED00180209 $t Current hypertension reports $x 1534-3111 $g Roč. 25, č. 9 (2023), s. 231-242
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37639176 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20231013 $b ABA008
- 991 __
- $a 20231026110030 $b ABA008
- 999 __
- $a ok $b bmc $g 2000056 $s 1202670
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 25 $c 9 $d 231-242 $e 20230828 $i 1534-3111 $m Current hypertension reports $n Curr Hypertens Rep $x MED00180209
- LZP __
- $a Pubmed-20231013